NeoGenomics, Inc. ("NeoGenomics" or the "Company") , a leading oncology testing services company, today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan. "We ...
Conservio, the go-to platform for travellers looking to escape into nature, has just landed $1 million in funding to expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback